Cellectis S.A. (FRA:ZVAA)

Cellectis Statistics

Total Valuation

Cellectis has a market cap or net worth of EUR 293.28 million. The enterprise value is 324.48 million.

Market Cap	293.28M
Enterprise Value	324.48M

Important Dates

The next estimated earnings date is Tuesday, March 10, 2026.

Earnings Date	Mar 10, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+22.47%
Shares Change (QoQ)	+2.84%
Owned by Insiders (%)	2.20%
Owned by Institutions (%)	7.24%
Float	42.29M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	4.17
PB Ratio	3.42
P/TBV Ratio	3.45
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-10.77
EV / Sales	4.61
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-12.08

Financial Position

The company has a current ratio of 1.49, with a Debt / Equity ratio of 0.88.

Current Ratio	1.49
Quick Ratio	0.53
Debt / Equity	0.88
Debt / EBITDA	n/a
Debt / FCF	-2.82
Interest Coverage	-3.31

Financial Efficiency

Return on equity (ROE) is -30.75% and return on invested capital (ROIC) is -8.08%.

Return on Equity (ROE)	-30.75%
Return on Assets (ROA)	-4.47%
Return on Invested Capital (ROIC)	-8.08%
Return on Capital Employed (ROCE)	-13.58%
Revenue Per Employee	321,270
Profits Per Employee	-137,586
Employee Count	222
Asset Turnover	0.22
Inventory Turnover	n/a

Taxes

In the past 12 months, Cellectis has paid 438,082 in taxes.

Income Tax	438,082
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +130.05% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+130.05%
50-Day Moving Average	3.24
200-Day Moving Average	1.97
Relative Strength Index (RSI)	72.46
Average Volume (20 Days)	637

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Cellectis had revenue of EUR 70.36 million and -30.13 million in losses. Loss per share was -0.30.

Revenue	70.36M
Gross Profit	70.36M
Operating Income	-22.50M
Pretax Income	-29.69M
Net Income	-30.13M
EBITDA	-11.82M
EBIT	-22.50M
Loss Per Share	-0.30

Balance Sheet

The company has 44.53 million in cash and 75.73 million in debt, giving a net cash position of -31.20 million.

Cash & Cash Equivalents	44.53M
Total Debt	75.73M
Net Cash	-31.20M
Net Cash Per Share	n/a
Equity (Book Value)	85.64M
Book Value Per Share	1.18
Working Capital	61.89M

Cash Flow

In the last 12 months, operating cash flow was -24.79 million and capital expenditures -2.07 million, giving a free cash flow of -26.86 million.

Operating Cash Flow	-24.79M
Capital Expenditures	-2.07M
Free Cash Flow	-26.86M
FCF Per Share	n/a

Margins

Gross margin is 100.00%, with operating and profit margins of -31.99% and -42.83%.

Gross Margin	100.00%
Operating Margin	-31.99%
Pretax Margin	-42.20%
Profit Margin	-42.83%
EBITDA Margin	-16.81%
EBIT Margin	-31.99%
FCF Margin	n/a

Dividends & Yields

Cellectis does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-22.47%
Shareholder Yield	-22.47%
Earnings Yield	-10.27%
FCF Yield	-9.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Cellectis has an Altman Z-Score of -0.68 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.68
Piotroski F-Score	3